Disposition of Intravenous Ketorolac

NCT01291472 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitaire Ziekenhuizen KU Leuven